BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11732770)

  • 1. Prenatal intracranial hemorrhage and neurologic complications in alloimmune thrombocytopenia.
    Sharif U; Kuban K
    J Child Neurol; 2001 Nov; 16(11):838-42. PubMed ID: 11732770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal treatment of alloimmune thrombocytopenia.
    Lynch L; Bussel JB; McFarland JG; Chitkara U; Berkowitz RL
    Obstet Gynecol; 1992 Jul; 80(1):67-71. PubMed ID: 1603500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage.
    Kanhai HH; van den Akker ES; Walther FJ; Brand A
    Fetal Diagn Ther; 2006; 21(1):55-60. PubMed ID: 16354976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
    Cook TJ; Qiu CC; Dickinson JE
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of alloimmune neonatal thrombocytopenia.
    Blanchette VS; Johnson J; Rand M
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal alloimmune thrombocytopenia: antenatal management.
    Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
    Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of feto-maternal alloimmune thrombocytopenia: report of three cases.
    Paternoster DM; Cester M; Memmo A; Scandellari R; Fabris F; Girolami A
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):517-20. PubMed ID: 16966118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal alloimmune thrombocytopenia].
    Schechter Y; Zeides I; Shalev E; Sharon R
    Harefuah; 1994 Dec; 127(12):505-8, 576. PubMed ID: 7813921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage.
    Yinon Y; Spira M; Solomon O; Weisz B; Chayen B; Schiff E; Lipitz S
    Am J Obstet Gynecol; 2006 Oct; 195(4):1153-7. PubMed ID: 17000248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal treatment of neonatal alloimmune thrombocytopenia.
    Bussel JB; Berkowitz RL; McFarland JG; Lynch L; Chitkara U
    N Engl J Med; 1988 Nov; 319(21):1374-8. PubMed ID: 3141811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy.
    Kaplan C
    Transfus Clin Biol; 2001 Jun; 8(3):311-4. PubMed ID: 11499984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
    Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
    Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is a non-invasive management allowed for maternofetal alloimmune thrombocytopenia? Experience over a 10-year period].
    Deruelle P; Wibaut B; Manessier L; Subtil D; Vaast P; Puech F; Valat AS
    Gynecol Obstet Fertil; 2007 Mar; 35(3):199-204. PubMed ID: 17306591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of gradual conversion to a less invasive therapeutic strategy for pregnant women with alloimmune thrombocytopenia in the fetus for prevention of intracranial hemorrhage].
    Radder CM; Kanhai HH; de Beaufort AJ; Klumper FJ; Brand A
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2015-8. PubMed ID: 11072521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia.
    Thung SF; Grobman WA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1094-9. PubMed ID: 16157118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of fetal and neonatal alloimmune thrombocytopenia.
    Kaplan C; Daffos F; Forestier F; Morel-Kopp MC; Tchernia G
    Vox Sang; 1994; 67 Suppl 3():85-8. PubMed ID: 7975518
    [No Abstract]   [Full Text] [Related]  

  • 18. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates.
    Bussel JB; Primiani A
    Blood Rev; 2008 Jan; 22(1):33-52. PubMed ID: 17981381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families.
    Kanhai HH; Porcelijn L; van Zoeren D; Klumper F; Viƫtor H; Meerman RH; Brand A
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):67-73. PubMed ID: 8886684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
    Rayment R; Brunskill SJ; Stanworth S; Soothill PW; Roberts DJ; Murphy MF
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004226. PubMed ID: 15674934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.